LUCID CAPITAL MARKETS Initiates Coverage On Xtant Medical Holdings with Buy Rating, Announces Price Target of $1
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Xtant Medical Holdings (AMEX:XTNT) with a Buy rating and announces Price Target of $1.
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Xtant Medical Holdings (AMEX:XTNT) with a Buy rating and announces Price Target of $1.